Three plasmids (an FP donor vector, a frame selector Cas9/sgRNA vector and a target Cas9/sgRNA vector) were transfected into mESCs using Lipofectamine 2000 (Thermo Fisher Scientific, 11668027). The molar ratio of [donor vector]:[frame selector]:[target sgRNA] plasmid was typically 20:1:1, and was achieved using 364 ng minicircle donor, 130 ng target Cas9/sgRNA vector and 130 ng frame selector. The three plasmids were mixed and diluted to 50 µl in Opti-MEM Medium (Gibco, 31985062). 1.25 µl Lipofectamine 2000 was diluted to 50 µl in Opti-MEM Medium, then added to the 50 μl of DNA solution and incubated at room temperature for 5 min. After incubation, the 100 μl DNA/Lipofectamine 2000 mixture was transferred to a gelatin-coated 12-well plate. 5×105 single cells in suspension per well were added to DNA/Lipofectamine 2000 mixture. 2i/LIF was added up to 1 ml per well. The same procedures were performed with 50 μl of pure Opti-MEM Medium and 50 μl of diluted Lipofectamine 2000 as a negative control. The transfection mixture was replaced with 2-3 ml of fresh 2i/LIF and mCherry-Cas9 signal observed in the transfected cells the following day. Triplicates of co-transfection were used for each gene tagging. Table S4 lists plasmids that were co-transfected in each experiment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.